
SPRY
Healthcare · Biotechnology · $391.1M market cap
$3.89+0.08 (+2.1%)Nov 13, 4:15 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +19.9% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | After the close | -0.34 | -0.36 | -5.9% |
| Aug 13, 2026 | After the close | -0.55 | -0.63 | -14.5% |
| May 15, 2026 | Before the open | -0.53 | -0.61 | -15.1% |
| Mar 19, 2026 | Time not confirmed | -0.42 | -0.42 | +1.1% |
| Nov 10, 2025 | Before the open | -0.49 | -0.52 | -6.1% |
| Aug 13, 2025 | Before the open | -0.51 | -0.46 | +9.8% |
| May 14, 2025 | Before the open | -0.36 | -0.35 | +2.8% |
| Mar 19, 2025 | Before the open | -0.12 | 0.51 | +534.0% |
| Nov 13, 2024 | Before the open | -0.14 | -0.20 | -42.9% |
| Aug 6, 2024 | After the close | -0.11 | -0.13 | -18.2% |
| May 9, 2024 | After the close | -0.11 | -0.11 | 0.0% |
| Mar 21, 2024 | After the close | -0.14 | -0.07 | +50.0% |
| Nov 9, 2023 | After the close | -0.18 |
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in…
| -0.16 |
| +11.1% |
| Aug 10, 2023 | After the close | -0.16 | -0.18 | -12.5% |
| May 15, 2023 | Before the open | -0.15 | -0.16 | -6.7% |
| Mar 23, 2023 | After the close | -0.13 | 0.77 | +692.3% |
| Nov 2, 2022 | After the close | -0.35 | -0.50 | -42.9% |
| Aug 11, 2022 | After the close | -0.48 | -0.55 | -14.6% |
| May 12, 2022 | After the close | -0.54 | -0.70 | -29.6% |
| Mar 31, 2022 | After the close | -0.70 | -0.67 | +4.3% |
| Nov 10, 2021 | After the close | -0.67 | -0.65 | +3.0% |
| Aug 12, 2021 | After the close | -0.53 | -0.70 | -32.1% |
| May 13, 2021 | After the close | -0.35 | -0.54 | -54.3% |
| Mar 29, 2021 | After the close | -0.49 | -1.37 | -179.6% |
| Nov 10, 2020 | After the close | -1.10 | -0.70 | +36.4% |